investment analyst coverage
Pacific Biosciences Says More Sequencers in Development Pipeline, Outlines Future Growth Plans
Premium
The company hosted its first investor day this week, offering a glimpse of its near-term product roadmap while laying out its growth plans through 2026.
Craig-Hallum Initiates Coverage of Guardant Health With Buy Rating
The investment bank focused mainly on its expectations for Guardant's colorectal cancer screening assay, but also argued its overall business is poised for significant growth.
Craig-Hallum Downgrades Exact Sciences to Hold, Lowers Price Target to $35
Analysts for the bank cited expected competition from Guardant Health's blood-based colorectal cancer test, as well as market challenges for Exact's Cologuard.
Cowen Initiates Coverage of 23andMe With Outperform Rating
The investment bank pointed to 23andMe's unique and hard-to-replicate population-scale genetic database as a key growth driver.
UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies
The investment bank also released an updated rating for Danaher as it expanded its coverage of the life science tools and diagnostic market.